15, Jul 2026
ten23 health expands excipient options for biologic drug development with an external collaboration
Basel, Switzerland. July 15 — ten23 health® today highlights its research collaboration with dsm-firmenich, focused on expanding excipient options for parenteral biologic drug products. By combining complementary expertise, the collaboration aims to address one of the longstanding challenges in biologic formulation development: the limited availability of excipients suitable for injectable medicines.
As biologic therapies become increasingly complex, formulation scientists face growing challenges in achieving product stability, manufacturability, and long-term performance. While excipients play a critical role in addressing these challenges, relatively few are available for parenteral biologic applications, limiting formulation flexibility.
Through this collaboration, ten23 health contributes its expertise in formulation development for sterile products, analytical characterization and pharmaceutical manufacturing, while dsm-firmenich brings extensive capabilities in pharmaceutical ingredient science, quality systems and regulatory support. Together, the teams are evaluating pharmaceutical-grade ingredients with established safety profiles as potential excipient candidates for biologic formulations.
The research follows a structured scientific approach, including proof-of-concept studies, benchmarking against established excipients and evaluation in representative protein formulations using advanced analytical methods. Initial findings have identified promising candidates, which are currently undergoing further verification and characterization.
“Our approach has been to identify promising ingredients based on their safety profiles, regulatory acceptance, and suitability for biologic formulations,” said Prof. Dr. Andrea Allmendinger, Chief Scientific Officer at ten23 health. “Following proof-of-concept studies and advanced analytical evaluation in representative protein formulations, we have generated promising initial data, which is now being further verified.”
When successful, the collaboration could help pharmaceutical developers improve formulation stability, enhance manufacturability and increase flexibility during product development. Expanding excipient options may also contribute to more efficient development processes and support the design of drug products better suited to patient needs, including self-administration and improved usability.
The collaboration reflects a shared commitment by both organizations to advancing biologic drug development through scientific excellence, responsible innovation and cross-disciplinary collaboration.
- 0
- By Neel Achary
15, Jul 2026
Gujarat’s Shipbuilding Sector Gets Fresh Push with Centre’s Project Approval
July 15: The Centre has approved two major shipbuilding projects in Gujarat under a development scheme aimed at strengthening India’s maritime manufacturing capabilities and promoting growth in the shipbuilding sector.
The projects are expected to enhance domestic shipbuilding infrastructure, encourage investment, and support the expansion of India’s maritime ecosystem. The initiative is part of the government’s broader efforts to improve self-reliance in strategic sectors and position India as a competitive player in global shipbuilding.
Officials said the projects will help develop advanced shipbuilding facilities while creating new opportunities for industries, skilled workers, and allied sectors connected to maritime activities.
The initiative is also expected to contribute to employment generation, technology development, and improved capabilities in ship construction and related services.
With Gujarat’s strong coastal advantage and growing industrial base, the approved projects are likely to play an important role in strengthening the state’s position as a key maritime hub.
The move reflects the government’s continued focus on expanding India’s blue economy, enhancing manufacturing capacity, and building a stronger presence in the global maritime industry.
15, Jul 2026
Zeelab Pharmacy Crosses 300 Company-Owned Stores, Strengthens Omni-channel Growth with 5,000 Daily Online Orders
New Delhi, 15th July: Zeelab Pharmacy, one of India’s fastest-growing pharmacy retail brands, has crossed 300 company–owned company-operated (COCO) stores and 5,000 daily orders through its e-commerce platform, marking a major milestone in its omni–channel growth journey. The achievement reinforces Zeelab’s position as one of India’s fastest-scaling pharmacy networks, driven by a technology-enabled omni–channel model focused on making quality healthcare more accessible and affordable.
The company achieved the 300-store milestone while its digital platform surpassed 5,000 daily orders within just four years of launch, reflecting strong customer adoption across metropolitan cities as well as Tier II and Tier III markets. Together, these milestones highlight the growing acceptance of Zeelab’s integrated “phygital” healthcare model, which combines a company–owned retail network with digital convenience to deliver affordable medicines at scale.
Over the last six months, Zeelab has expanded its footprint by adding nearly 15 company–owned stores every month, with its strongest presence across Delhi-NCR, Uttar Pradesh, Maharashtra and West Bengal. By March 2027, it aims to achieve 15,000 daily online orders, 35,000 daily offline orders and a significantly larger retail footprint.
Commenting on the milestone, Rohit Mukul, Founder and Chief Executive Officer, Zeelab Pharmacy, said, “Crossing 300 company–owned stores is more than a growth milestone, it reflects our conviction that quality healthcare can be made affordable at scale. India remains one of the world’s largest pharmaceutical markets, yet out-of-pocket healthcare expenditure continues to place a significant burden on millions of families. At Zeelab, we are addressing this gap by combining an integrated retail network, technology-led operations and a robust supply chain to make trusted, high-quality medicines accessible to more people. As we continue to expand, our ambition is clear, to build India’s most trusted affordable healthcare platform by setting new benchmarks in accessibility, affordability and customer experience.”
Zeelab’s integrated omni–channel model has become a key growth driver, enabling customers to access medicines seamlessly through both physical stores and digital channels. Pharmaceutical products account for approximately 60% of the company’s business, while wellness, personal care and over-the-counter healthcare products contribute the remaining 40%. Online demand continues to be led by chronic therapies, including diabetes and cardiac medicines, alongside rapidly growing skincare and haircare categories. The platform currently offers more than 1,200 products, serving customers across urban and emerging markets.
The company’s affordability-led model is also improving healthcare outcomes by enabling more consumers to purchase complete prescribed treatment regimens, supporting better treatment adherence. To guide future expansion, Zeelab leverages AI-enabled location intelligence, e-commerce demand heat maps and retail performance analytics to identify underserved, high-potential markets and optimise network expansion.
Looking ahead, Zeelab plans to accelerate its expansion across high-growth markets, including Uttar Pradesh, Bihar, Delhi-NCR, Telangana and West Bengal, while strengthening its presence in existing geographies. The company will continue to build its integrated healthcare ecosystem and advance its mission of making quality healthcare affordable and accessible to millions of Indians.
15, Jul 2026
From Fabrics to Cars: Indian Industries Set to Gain from UK Trade Agreement
July 15: The India-UK Free Trade Agreement (FTA) is expected to create significant growth opportunities for key sectors such as textiles, footwear, and automobiles, with businesses looking to maximise the benefits of improved market access and reduced trade barriers.
According to industry assessments, the agreement could help Indian exporters enhance their presence in the UK market by improving competitiveness, encouraging new investments, and creating opportunities for expansion across multiple sectors.
The textile and apparel industry is expected to gain from better export prospects, while the footwear sector may benefit from increased demand and easier access to one of the world’s major consumer markets. The automobile sector is also likely to explore new opportunities through stronger trade relations and improved business collaboration.
Experts believe the FTA will provide a broader platform for Indian companies to integrate more closely with global supply chains and strengthen their export capabilities.
The agreement is also expected to encourage innovation, attract investment, and support employment generation across manufacturing and allied industries.
With the India-UK trade partnership entering a new phase, industry stakeholders are focusing on leveraging the opportunities to boost exports, expand global reach, and contribute to India’s economic growth.
15, Jul 2026
Sensex, Nifty Bounce Back as Financial Stocks Drive Market Recovery
July 15: Indian stock markets ended on a positive note after a volatile trading session, with the Sensex and Nifty closing higher, driven by strong performance in banking and financial sector stocks.
The benchmark indices witnessed fluctuations during the day as investors reacted to market developments and global cues. However, buying interest in key banking and financial stocks helped markets regain momentum and finish in the green.
Banking shares emerged as the major contributors to the market’s recovery, providing support to the broader indices. Investors also tracked sectoral trends and corporate developments while maintaining a cautious approach amid market volatility.
Market analysts said the strength in financial stocks helped offset pressure in some other sectors, allowing the indices to close with gains. The positive movement reflected improved investor sentiment despite intraday fluctuations.
The trading session highlighted continued market resilience as investors balanced domestic economic factors, global trends, and sector-specific developments.
With banking and financial stocks leading the rally, the Indian equity market ended the session on a firm note, offering positive momentum ahead of future trading sessions.
15, Jul 2026
New Urea Policy 2026: Government Aims to Strengthen Fertiliser Supply Chain
July 15: The Union Cabinet has approved the National Urea Investment Policy 2026, a major initiative aimed at boosting domestic fertiliser production and strengthening India’s agricultural supply chain.
The policy is designed to encourage investment in the urea manufacturing sector, expand production capacity, and reduce the country’s dependence on imported fertilisers. It is expected to support long-term fertiliser security while ensuring a steady supply of urea for farmers.
Officials said the new framework will help create a more favourable environment for investments in the fertiliser industry by promoting modern technologies, improving efficiency, and encouraging expansion of existing facilities.
The initiative comes as part of the government’s broader efforts to enhance self-reliance in critical sectors and ensure timely availability of essential agricultural inputs. Increased domestic production of urea is expected to benefit farmers by improving supply stability and supporting agricultural productivity.
The policy is also expected to generate employment opportunities, promote industrial growth, and contribute to the development of a stronger fertiliser manufacturing ecosystem in the country.
With the approval of the National Urea Investment Policy 2026, the government aims to build a more resilient fertiliser sector and strengthen India’s journey towards greater self-sufficiency in agricultural inputs.
15, Jul 2026
July 2026 Patch Tuesday: Comment from Satnam Narang, Sr. Staff Research Engineer, Tenable
We knew this day would come. June 2026 Patch Tuesday broke the record, and July blew the record out of the water. July is the first time in Patch Tuesday’s history that over 500 CVEs were patched in a single month, with a staggering 569 CVEs patched, breaking last month’s record of 198 CVEs. Normally we have the wait for October or November to determine if we’ll break the previous year’s patch volume record, but July has locked it in that 2026 will be the largest annual Patch Tuesday ever, besting the previous record of 1,245 CVEs in 2020. It’s probable that we will not only exceed 2,000 CVEs in a calendar year, but potentially over 3,000 CVEs this year or more.
- The two flaws exploited in the wild are both elevation of privilege vulnerabilities. CVE-2026-56155, an Active Directory Federation Services (AD FS) flaw, and CVE-2026-56164, a Microsoft SharePoint Server vulnerability.
- CVE-2026-50661, a security feature bypass in Windows BitLocker, was noted as being publicly disclosed. We surmise that this could be related to a flurry of zero-day vulnerabilities disclosed by the researcher known as Nightmare-Eclipse or Chaotic-Eclipse, though no official confirmation was made. We also know that the researcher promised to drop something on Patch Tuesday.
While these were the noteworthy flaws this month, in addition to the 59 critical CVEs disclosed, the state of the Exploitability Index (how likely a vulnerability is to be exploited) must shift with the machine speed of discovery. For example, Microsoft originally tagged CVE-2026-45659, a SharePoint vulnerability, as exploitation less likely. However, the vulnerability was added to the CISA KEV on July 1. Anthropic’s Red Team’s own findings for known vulnerabilities (n-days) revealed how fragile this system has become, with its Mythos Preview model being able to produce proof-of-concept exploits for 13 of 14 vulnerabilities that were rated “Exploitation Less Likely” or “Exploitation Unlikely.” What this means is that our way of looking at Patch Tuesday has changed, because the exploitability index is centered around humans, not AI tools, and as these tools continue to improve, defense needs to improve alongside it. – Satnam Narang, Senior Staff Research Engineer at Tenable
15, Jul 2026
New Relic Announces Hein Hellemons as Chief Revenue Officer
Enterprise software veteran brings a proven track record of scaling high-performing global sales organizations and driving revenue growth across AWS, Microsoft, and VMware
Bengaluru, India – July 15: New Relic, the Intelligent Observability company, announced the appointment of Hein Hellemons as Chief Revenue Officer (CRO). Hellemons will oversee the company’s worldwide revenue and go-to-market strategy, leading global sales, commercial segments, and partner channel organizations to drive predictable, substantial growth.
Hellemons brings to New Relic more than 25 years of experience leading global go-to-market organizations at some of the world’s leading enterprise technology companies. Most recently, he served as CRO at Darktrace, a global leader in AI-powered cybersecurity. Prior to Darktrace, Hellemons held senior leadership positions at companies including Amazon Web Services (AWS), Microsoft, and VMware, where he helped enterprise customers accelerate their digital transformation journeys while building and scaling high-performing global sales organizations.
“As AI transforms how software is built and operated, AI-strengthened observability has become foundational for modern businesses. This presents a tremendous market opportunity for us,” said New Relic Chief Executive Officer Ashan Willy. “Hein is a world-class revenue leader who brings to New Relic invaluable experience leading companies through periods of growth and transformation. His background scaling global GTM organizations will be crucial as we expand our platform, deepen customer relationships, and accelerate growth. We are thrilled to welcome him to the leadership team.”
Hellemons joins New Relic as the company accelerates its footprint across global enterprises that are scaling AI. Reporting into Willy, Hellemons will cultivate high-performing teams and foster a strong execution culture, guiding the company through its next phase of growth with a focus on operational excellence and customer success.
“I was drawn to New Relic by the immense market opportunity, its outstanding platform, highly respected brand and talented leadership team,” said Hellemons. “New Relic is uniquely positioned to help companies succeed in the AI era and I’m excited to be part of this effort. I’m looking forward to working with Ashan and the rest of the executive team.”
15, Jul 2026
ManageEngine Completes the Certificate Life Cycle Management Loop With CA-Agnostic, Zero-Touch Automation
Cairo, Egypt, July 15 – ManageEngine, a division of Zoho Corporation and a leading provider of enterprise IT management and security solutions, today announced post-deployment automation for TLS certificates in Key Manager Plus, its certificate life cycle and machine identity management solution. Key Manager Plus now automates the final stages of certificate renewal, pushing certificates to the target server, running configured scripts, restarting dependent services, and notifying stakeholders, so the whole certificate life cycle runs without manual intervention.
Historically, most organizations did not have much incentive to automate certificate management. Even the ones that did adopt automation workflows limited it to discovery, periodic expiration alerts, and in some instances, automated renewals. That changed when the CA/Browser Forum voted to reduce the maximum validity of public TLS certificates, phasing down from the legacy 398-day validity period to a 200-day period in March 2026 (current cadence), which will drop to 100 days by March 2027, and finally 47 days by March 2029.
“We’re going from under 200 certificates to over 2,000, across a lot of domains, different server setups, credentials and post-deployment actions for nearly all of it. We’ve had to dedicate significant engineering time to certificate management alone since the change to 200 days. With the 47-day certificate renewals coming up, automation is the only way we can keep up, and Key Manager Plus’ CA-agnostic, certificate life cycle management has helped us automate the whole thing,” said Jonathan Choiniere, infrastructure manager at RevSpring, a payment solutions provider based in Nashville, Tennessee.
Automating the Last Mile of Certificate Renewal
Getting the certificate live is the last step in the renewal process, and this post-deployment task has primarily been handled manually by many teams. While this works when teams are renewing one certificate a year, as certificate lifespans shrink and the same steps repeat roughly eight times as often, manual errors become more likely and the cost of an outage can run into the millions.
“Certificate renewal is rarely the hard part. The work that piles up on teams is what comes after it, at scale: pushing certificates to the server, restarting the services, and confirming they actually went live. End-to-end automation is what turns a 47-day renewal cycle from a scramble into something that runs on its own. With Key Manager Plus, we are eliminating the last manual step in the life cycle management loop,” said Vasudevan Seshadri, director of product management at ManageEngine.
Quantifying the 47-Day Shift
To help organizations assess their own exposure to the reduced certificate validity mandate, ManageEngine has also released a 47-day TLS impact calculator. It lets enterprises quantify what the mandate means for them based on three factors: the size of their certificate estate, their current renewal labor, and their outage exposure. From there, it compares those numbers against what they will look like once their TLS certificate life cycle is fully automated. That automation is what Key Manager Plus delivers, and it runs identically whether teams deploy on-premises or in the cloud.
15, Jul 2026
NSE, Augmont Partner to Strengthen India’s Electronic Gold Receipt Ecosystem
July 15: The National Stock Exchange of India (NSE) has partnered with Augmont to strengthen India’s Electronic Gold Receipt (EGR) ecosystem, marking a significant step towards developing a more transparent and organised gold market.
The partnership aims to encourage wider adoption of Electronic Gold Receipts, providing investors with a modern and efficient way to hold and trade gold through digital platforms backed by physical gold.
The initiative is expected to improve transparency, enhance price discovery, and create greater participation in the formal gold market. It will also help bridge the gap between traditional gold ownership and emerging financial market solutions.
Electronic Gold Receipts offer investors the convenience of digital ownership while reducing the challenges associated with storing physical gold. The platform-based approach is designed to provide a secure, efficient, and accessible option for individuals and institutions interested in gold investments.
The collaboration between NSE and Augmont is expected to benefit various stakeholders, including investors, jewellers, traders, and other participants in the gold value chain, by supporting a more structured and transparent trading ecosystem.
The move reflects the growing efforts to modernise India’s gold market and strengthen the role of technology in creating efficient financial solutions. The partnership is expected to contribute towards wider acceptance of digital gold instruments and support the formalisation of gold trading in India.
